1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19
on Global Cancer Microbiome Sequencing Market
5. Voice of Customer
6.
Global Cancer Microbiome Sequencing Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Component (Kits & Assays, Software, Services)
6.2.2. By Technology (Next Generation Sequencing v/s Polymerase
Chain Reaction)
6.2.3. By Application (Translational Research v/s Clinical
Diagnostics)
6.2.4. By End User (Biotechnology & Pharmaceutical
Companies, Academic & Research Institutions, Hospitals & Clinics,
Others)
6.2.5. By Company (2021)
6.2.6. By Region
6.3. Market Map
7.
North America Cancer Microbiome Sequencing Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1. By Component
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. North America:
Country Analysis
7.3.1. United States Cancer
Microbiome Sequencing Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Component
7.3.1.2.2.
By Technology
7.3.1.2.3.
By Application
7.3.1.2.4.
By End User
7.3.2. Canada Cancer
Microbiome Sequencing Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Component
7.3.2.2.2.
By Technology
7.3.2.2.3.
By Application
7.3.2.2.4.
By End User
7.3.3. Mexico Cancer
Microbiome Sequencing Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Component
7.3.3.2.2.
By Technology
7.3.3.2.3.
By Application
7.3.3.2.4.
By End User
8.
Europe Cancer Microbiome Sequencing Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1. By Component
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Europe: Country
Analysis
8.3.1. France Cancer
Microbiome Sequencing Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Component
8.3.1.2.2.
By Technology
8.3.1.2.3.
By Application
8.3.1.2.4.
By End User
8.3.2. Germany Cancer
Microbiome Sequencing Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Component
8.3.2.2.2.
By Technology
8.3.2.2.3.
By Application
8.3.2.2.4.
By End User
8.3.3. United Kingdom Cancer
Microbiome Sequencing Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Component
8.3.3.2.2.
By Technology
8.3.3.2.3.
By Application
8.3.3.2.4.
By End User
8.3.4. Italy Cancer
Microbiome Sequencing Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Component
8.3.4.2.2.
By Technology
8.3.4.2.3.
By Application
8.3.4.2.4.
By End User
8.3.5. Spain Cancer
Microbiome Sequencing Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Component
8.3.5.2.2.
By Technology
8.3.5.2.3.
By Application
8.3.5.2.4.
By End User
9.
Asia-Pacific Cancer Microbiome Sequencing Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1. By Component
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. Asia-Pacific:
Country Analysis
9.3.1. China Cancer
Microbiome Sequencing Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Component
9.3.1.2.2.
By Technology
9.3.1.2.3.
By Application
9.3.1.2.4.
By End User
9.3.2. India Cancer
Microbiome Sequencing Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Component
9.3.2.2.2.
By Technology
9.3.2.2.3.
By Application
9.3.2.2.4.
By End User
9.3.3. Japan Cancer
Microbiome Sequencing Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Component
9.3.3.2.2.
By Technology
9.3.3.2.3.
By Application
9.3.3.2.4.
By End User
9.3.4. South Korea Cancer
Microbiome Sequencing Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Component
9.3.4.2.2.
By Technology
9.3.4.2.3.
By Application
9.3.4.2.4.
By End User
9.3.5. Australia Cancer
Microbiome Sequencing Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Component
9.3.5.2.2.
By Technology
9.3.5.2.3.
By Application
9.3.5.2.4.
By End User
10.
South America Cancer Microbiome Sequencing Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Component
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Cancer
Microbiome Sequencing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Component
10.3.1.2.2.
By Technology
10.3.1.2.3.
By Application
10.3.1.2.4.
By End User
10.3.2. Argentina Cancer
Microbiome Sequencing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Component
10.3.2.2.2.
By Technology
10.3.2.2.3.
By Application
10.3.2.2.4.
By End User
10.3.3. Colombia Cancer
Microbiome Sequencing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Component
10.3.3.2.2.
By Technology
10.3.3.2.3.
By Application
10.3.3.2.4.
By End User
11.
Middle East and Africa Cancer Microbiome Sequencing Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Component
11.2.2. By Technology
11.2.3. By Application
11.2.4. By End User
11.2.5. By Country
11.3.
MEA: Country Analysis
11.3.1. South Africa Cancer
Microbiome Sequencing Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Component
11.3.1.2.2.
By Technology
11.3.1.2.3.
By Application
11.3.1.2.4.
By End User
11.3.2. Saudi Arabia Cancer
Microbiome Sequencing Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Component
11.3.2.2.2.
By Technology
11.3.2.2.3.
By Application
11.3.2.2.4.
By End User
11.3.3. UAE Cancer
Microbiome Sequencing Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Component
11.3.3.2.2.
By Technology
11.3.3.2.3.
By Application
11.3.3.2.4.
By End User
11.3.4. Turkey Cancer
Microbiome Sequencing Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1.
By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1.
By Component
11.3.4.2.2.
By Technology
11.3.4.2.3.
By Application
11.3.4.2.4.
By End User
11.3.5. Egypt Cancer
Microbiome Sequencing Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1.
By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1.
By Component
11.3.5.2.2.
By Technology
11.3.5.2.3.
By Application
11.3.5.2.4.
By End User
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14. Competitive
Landscape
14.1.
Illumina, Inc.
14.2.
Eurofins Scientific SE
14.3.
QIAGEN NV
14.4.
Thermo Fischer Scientific, Inc.
14.5.
Oxford Nanopore Technologies plc.
14.6.
OraSure Technologies, Inc.
14.7.
Pacific Biosciences of California, Inc.
14.8.
Psomagen, Inc
14.9.
Prescient Medicine Holdings, Inc.
14.10.
Micronoma Inc.
15. Strategic Recommendations